(Q26851409)

C. Harstall

2

1 reference

T. Louie

3

1 reference

S. Veldhuyzen van Zanten

4

1 reference

L. A. Dieleman

5

1 reference

language of work or name

1 reference

April 2012

1 reference

Alimentary Pharmacology & Therapeutics

published in

1 reference

volume

35

1 reference

issue

8

1 reference

page(s)

865-75

1 reference

Implications of the changing face of Clostridium difficile disease for health care practitioners

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Clostridium difficile associated infection, diarrhea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Antimicrobial-associated risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Fecal bacteriotherapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Endoscopic fecal microbiota transplantation: "first-line" treatment for severe clostridium difficile infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Best strategies in recurrent or persistent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Clostridium difficile: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Alternative strategies for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Treatment of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Recent advances in Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Recurrent Clostridium difficile infection: what are the treatment options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Treatment of recurrent Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Treatment of refractory and recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Bacteriotherapy using fecal flora: toying with human motions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Review article: faecal transplantation therapy for gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Systematic reviews: synthesis of best evidence for clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Success of self-administered home fecal transplantation for chronic Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

21 January 2018

Observational studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

7 January 2021

Clostridium difficile

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

7 January 2021

Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

7 January 2021

Modified fecal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

7 January 2021

Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05033.X

7 January 2021